WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in A — Agilent Technologies, Inc.

CIK 1632972 PLYMOUTH, MN

Position in A

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$13,811,397

+$3,548,068 QoQ

Shares Held

103,978

+15.5% QoQ

Ownership

0.037%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

of 113 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 2.771766833049617.ToString("F0")% Shared 0.ToString("F0")% None 97.22823316695039.ToString("F0")%

Healthcare · as of Jun 30, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $184,108,370 across 28 Diagnostics & Research names. A ranks #6 (7.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	93,673	$46,963,895
2	DHR	Danaher Corp /De/	139,461	$26,564,531
3	ILMN	Illumina, Inc.	107,790	$18,952,715
4	LH	Labcorp Holdings Inc.	56,094	$15,706,320
5	NTRA	Natera, Inc.	55,459	$15,054,345
6	A	Agilent Technologies, Inc. This page	103,978	$13,811,397
7	MEDP	Medpace Holdings, Inc.	15,922	$8,432,131
8	IQV	Iqvia Holdings Inc.	42,028	$8,120,650

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,811,397	103,978	+15.5%	Shares	Sole	2026-07-15
2026-03-31	$10,263,329	90,045	+0.9%	Shares	Sole	2026-04-08
2025-12-31	$12,141,253	89,228	+3.0%	Shares	Sole	2026-01-08
2025-09-30	$11,122,297	86,656	-1.2%	Shares	Sole	2025-10-29
2025-06-30	$10,351,011	87,713	+70.8%	Shares	Sole	2025-07-10
2025-03-31	$6,008,443	51,363	+86.3%	Shares	Sole	2025-04-16
2024-12-31	$3,702,813	27,563	+32.9%	Shares	Sole	2025-03-17
2024-09-30	$3,078,732	20,735	-12.4%	Shares	Sole	2024-10-24
2024-06-30	$3,067,823	23,666	-5.7%	Shares	Sole	2024-07-16
2024-03-31	$3,653,319	25,107	+2.8%	Shares	Sole	2024-04-15
2023-12-31	$3,394,000	24,412	+23.0%	Shares	Sole	2024-01-30
2023-09-30	$2,219,291	19,847	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.